Comparative cytokine profile of human skin mast cells from two compartments - Strong resemblance with monocytes at baseline but induction of IL-5 by IL-4 priming

Journal of Leukocyte Biology

Volumn 75, Issue 2, 2004, Pages 244-252

  Babina, Magda ^a   Guhl, Sven ^a   Stärke, André ^a   Kirchhof, Loreen ^a   Zuberbier, Torsten ^a   Henz, Beate M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cell plasticity; Inflammation; Innate immunity; Interleukin

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; PHORBOL 13 ACETATE 12 MYRISTATE; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ANTIGEN PRESENTATION; ARTICLE; BREAST; CELL CULTURE; CELL ISOLATION; CELL LYSATE; CELL TYPE; COMPARTMENT MODEL; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INFLAMMATION; LONG TERM CARE; MAST CELL; MONOCYTE; PREPUCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN; TH2 CELL; UPREGULATION;

CULTURE MEDIA; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-4; INTERLEUKIN-5; MAST CELLS; MONOCYTES; SKIN; TH2 CELLS;

EID: 0842309947     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0403157     Document Type: Article

References (45)

1. Weber, S., Krüger-Krasagakes, S., Grabbe, J., Zuberbier, T., Czarnetzki, B. M. (1995) Mast cells. Int. J. Dermatol. 34, 1-10.
2. Metcalfe, D. D., Baram, D., Mekori, Y. A. (1997) Mast cells. Physiol. Rev. 77, 1033-1079.
3. Bell, R. G. (1996) IgE, allergies and helminth parasites: a new perspective on an old conundrum. Immunol. Cell Biol. 74, 337-345.
4. Miller, H. R. (1996) Mucosal mast cells and the allergic response against nematode parasites. Vet. Immunol. Immunopathol. 54, 331-336.
5. Mekori, Y. A., Metcalfe, D. D. (2000) Mast cells in innate immunity. Immunol. Rev. 173, 131-140.
6. Henz, B. M., Maurer, M., Lippert, U., Worm, M., Babina, M. (2001) Mast cells as initiators of immunity and host defense. Exp. Dermatol. 10, 1-10.
7. Malaviya, R., Georges, A. (2002) Regulation of mast cell-mediated innate immunity during early response to bacterial infection. Clin. Rev. Allergy Immunol. 22, 189-204.
8. Springer, T. A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314.
9. Bradding, P., Holgate, S. T. (1999) Immunopathology and human mast cell cytokines. Crit. Rev. Oncol. Hematol. 31, 119-133.
10. Lorentz, A., Schwengberg, S., Sellge, G., Manns, M. P., Bischoff, S. C. (2000) Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J. Immunol. 164, 43-48.
11. Bischoff, S. C., Sellge, G., Manns, M. P., Lorentz, A. (2001) Interleukin-4 induces a switch of human intestinal mast cells from proinflammatory cells to Th2-type cells. Int. Arch. Allergy Immunol. 124, 151-154.
12. Irani, A. A., Schechter, N. M., Craig, S. S., DeBlois, G., Schwartz, L. B. (1986) Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. USA 83, 4464-4468.
13. Bradding, P., Okayama, Y., Howarth, P. H., Church, M. K., Holgate, S. T. (1995) Heterogeneity of human mast cells based on cytokine content. J. Immunol. 155, 297-307.
14. Gibbs, B. F., Wierecki, J., Welker, P., Henz, B. M., Wolff, H. H., Grabbe, J. (2001) Human skin mast cells rapidly release preformed and newly generated TNF-α and IL-8 following stimulation with anti-IgE and other secretagogues. Exp. Dermatol. 10, 312-320.
15. Babina, M., Mammeri, K., Henz, B. M. (2001) Retinoic acid up-regulates myeloid ICAM-3 expression and function in a cell-specific fashion-evidence for retinoid signaling pathways in the mast cell lineage. J. Leukoc. Biol. 69, 361-372.
16. 2-integrins by human monocytes: opposite effects on monocytic cell lines. Eur. J. Immunol. 33, 616-625.
17. Weber, S., Babina, M., Krüger-Krasagakes, S., Grützkau, A., Henz, B. M. (1996) A subclone (5C6) of the human mast cell line HMC-1 represents a more differentiated phenotype than the original cell line. Arch. Dermatol. Res. 288, 778-782.
18. Butterfield, J. H., Weiler, D., Dewald, G., Gleich, G. J. (1988) Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 12, 345-355.
19. Siraganian, R. P. (1975) Automated histamine release. A method for in vitro diagnosis. Int. Arch. Allergy Appl. Immunol. 49, 108-110.
20. Murphy, J. E., Robert, C., Kupper, T. S. (2000) Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J. Invest. Dermatol. 114, 602-608.
21. Dinarello, C. A. (1997) Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings. J. Biol. Regul. Homeost. Agents 11, 91-103.
22. Opal, S. M., DePaolo, V. A. (2000) Anti-inflammatory cytokines. Chest 117, 1162-1172.
23. Biet, F., Locht, C., Kremer, L. (2002) Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J. Mol. Med. 80, 147-162.
24. Song, J. S., Haleem-Smith, H., Arudchandran, R., Gomez, J., Scott, P. M., Mill, J. F., Tan, T-H., Rivera, J. (1999) Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway. J. Immunol. 163, 802-810.
25. Van den Berghe, W., Vermeulen, L., De Wilde, G., De Bosscher, K., Boone, E., Haegeman, G. (2000) Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem. Pharmacol. 60, 1185-1195.
26. Bradding, P., Feather, I. H., Howarth, P. H., Mueller, R., Roberts, J. A., Britten, K., Bews, J. P. A., Hunt, T. C., Okayama, Y., Heusser, C. H., Bullock, G. R., Church, M. K., Holgate, S. T. (1992) Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176, 1381-1386.
27. Horsmanheimo, L., Harvima, I. T., Jarvikallio, A., Harvima, R. J., Naukkarinen, A., Horsmanheimo, M. (1994) Mast cells are one major source of interleukin-4 in atopic dermatitis. Br. J. Dermatol. 131, 348-353.
28. Pawankar, R., Okuda, M., Yssel, H., Okumura, K., Ra, C. (1997) Nasal mast cells in perennial rhinitics exhibit increased expression of the FcεRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 99, 1492-1499.
29. Baranes, D., Lewin, I., Razin, E. (1993) Serum modulates mast cell responses to IgE antigen stimulation. Eur. J. Immunol. 23, 291-294.
30. Lorentz, A., Schuppan, D., Gebert, A., Manns, M. P., Bischoff, S. C. (2002) Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins. Blood 99, 966-972.
31. Pahl, H. L. (1999) Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18, 6853-6866.
32. Echtenacher, B., Männel, D. N., Hültner, L. (1996) Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381, 75-77.
33. Malaviya, R., Ikeda, T., Ross, E., Abraham, S. N. (1996) Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381, 77-80.
34. Maurer, M., Echtenacher, B., Hültner, L., Kollias, G., Männel, D. N., Langley, K. E., Galli, S. J. (1998) The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med. 188, 2343-2348.
35. Biedermann, T., Kneilling, M., Mailhammer, R., Maier, K., Sander, C. A., Kollias, G., Kunkel, S. L. Hültner, L., Röcken, M. (2000) Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192, 1441-1452.
36. Von Stebut, E., Metz, M., Milon, G., Knop, J., Maurer, M. (2003) Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1α/β released from neutrophils recruited by mast cell-derived TNFα. Blood 101, 210-215,
37. McCurdy, J. D., Olynych, T. J., Maher, L. H., Marshall, J. S. (2003) Distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol. 170, 1625-1629.
38. Varadaradjalou, S., Féger, F., Thieblemont, N., Ben Hamouda, N., Pleau, J-P., Dy, M., Arock, M. (2003) Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 33, 899-906.
39. +, and expresses amino-peptidase N (CD13). Blood 94, 2333-2342.
40. Gersch, C., Dewald, O., Zoerlein, M., Michael, L. H., Entman, M. L., Frangogiannis, N. G. (2002) Mast cells and macrophages in normal C57/BL/6 mice. Histochem. Cell Biol. 118, 41-49.
41. Rugtveit, J., Nilsen, E. M., Bakka, A., Carlsen, H., Brandtzaeg, P., Scott, H. (1997) Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 112, 1493-1505.
42. Broide, D., Sriramarao, P. (2001) Eosinophil trafficking to sites of allergic inflammation. Immunol. Rev. 179, 163-172.
43. Gratchev, A., Schledzewski, K., Guillot, P., Goerdt, S. (2001) Alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing. Skin Pharmacol. Appl. Skin Physiol. 14, 272-279.
44. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555.
45. Agis, H., Füreder, W., Bankl, H. C., Kundi, M., Sperr, W. R., Willheim, M., Boltz-Nitulescu, G., Butterfield, J. H., Kishi, K., Lechner, K., Valent, P. (1996) Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 87, 535-543.